Plain-English translation of NCT07547605 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study compares three different injection treatments for a painful condition called myofascial pain syndrome that affects the upper trapezius muscle in your shoulder and neck. The three treatments being tested are: platelet-rich plasma (PRP) alone, platelet-rich plasma combined with betamethasone, and betamethasone alone. Each injection also contains a local anesthetic to numb the area during the procedure.
Many people with upper shoulder and neck muscle pain don't get relief from standard treatments like physical therapy and oral pain medication. Researchers want to see whether platelet-rich plasma—a substance made from your own blood that may help reduce inflammation and promote healing—can work better than steroid injections alone, or whether combining the two approaches works best.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive a single injection into your upper trapezius muscle guided by touch (without ultrasound). You will then be assessed at several time points: 1 week, 4 weeks, 3 months, and 6 months after the injection. At each visit, the research team will measure your pain level, how much your muscle tender point hurts when pressure is applied, how far you can move your neck, and whether you've needed any rescue pain medication. You will also be asked about your satisfaction with the treatment and whether your symptoms have returned.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Cyprus